Treatment | CCS patients (n = 20) | Controls (n = 14) | p |
---|---|---|---|
Treg cells, % living cells | |||
5 µM H2O2 | 74 (69–88) | 88 (77–94) | 0.246 |
10 µM H2O2 | 50 (44–58) | 58 (41–79) | 0.338 |
20 µM H2O2 | 9.6 (2.8–11) | 14 (8.8–29) | 0.159 |
30 µM H2O2 | 2.7 (2.2–4.2) | 3.9 (2.8–8.9) | 0.106 |
2.5 µM STS | 42 (30–52) | 47 (40–56) | 0.174 |
 | Tconv cells, % living cells |  | |
---|---|---|---|
5 µM H2O2 | 94 (92–99) | 98 (97–100) | 0.046 |
10 µM H2O2 | 85 (92–99) | 93 (87–98) | 0.030 |
20 µM H2O2 | 39 (35–67) | 69 (45–84) | 0.110 |
30 µM H2O2 | 24 (11–41) | 39 (21–57) | 0.199 |
2.5 µM STS | 80 (69–91) | 91 (88–95) | 0.014 |